Managing Partners

Who We Are

Value Genome, LLC. is a team of pharmaceutical and biotech executives with extensive real-world industry experience who share a common passion for assisting biopharmaceutical innovators in maximizing the pricing and reimbursement potential of their assets. We combine our medical, pricing, and reimbursement expertise with our extensive payer relations and direct product launch experience.

  • We collaborate with you in developing market access strategies by looking at the clinical development program through product launch and across your product life-cycle to reveal the CLINICAL and ECONOMIC VALUE of your asset as defined by key stakeholders.
  • We achieve this by engaging external stakeholders at all levels of health care delivery:
    • Government/Commercial Payers and Their Advisors
    • Physicians and Their Professional Societies
    • Healthcare and Insurance Networks
    • Patients and Patient Advocacy Organizations
    • Hospital and Treatment Centers
    • Health Technology Assessment Agencies
    • Ministry Officials
    • Health Economic Thought Leaders

The goal is to shape your clinical development program to be payer ready and to optimize your product access globally.

Strategic Collaborators and Advisors

Rapid Commercialization Partners, Inc. (RCP) is dedicated to accelerating commercial readiness for clinical-stage biotech companies and offers a foundational shift in how biotech companies can achieve commercial success and rapid time to value. Engaging a team of senior commercial leaders with comprehensive biotech experience and unparalleled proficiency in critical subject matter areas essential to support  commercialization, RCP works provides strategic and executional expertise on critical decision points early in the commercialization process to build the commercial foundation, address observable inefficiency, and bring needed therapies to patients  faster and with improved fiscal responsibility.

Stephen F Amato, Ph.D., MBA, RAC

Department Chair, Global Regulatory Affairs/Quality Assurance/ Advanced Manufacturering, Northeastern University

Joseph Eichenholz, MA

Chief US Value and Access Strategy Lead

Mark Rubino, R.Ph, M.B.A.

Retired, Former Chief Pharmacy Officer Value Genome LLC